# Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

> **NCT07067749** · PHASE3 · RECRUITING · sponsor: **University of Rome Tor Vergata** · enrollment: 92 (estimated)

## Conditions studied

- Bladder (Urothelial, Transitional Cell) Cancer
- Bladder Cancer Requiring Cystectomy
- Bladder Carcinoma
- Bladder Neoplasm
- Muscle Invasive Bladder Cancer (MIBC)

## Interventions

- **DIAGNOSTIC_TEST:** multiparametric magnetic resonance imaging (mpMRI) of the bladder
- **PROCEDURE:** Transurethral resection of bladder tumour (TURBt)
- **GENETIC:** Circulating tumour DNA levels assessment

## Key facts

- **NCT ID:** NCT07067749
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2028-08-15
- **Final completion:** 2030-08-15
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07067749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07067749, "Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07067749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*